iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in iSpecimen Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 6
- −6 vs. Q2 2024
- Shares held
- 38.9K
- −238.9K (−86.0%) vs. Q2 2024
- Total value
- $182.9K
- +$97.2K (+113.5%) vs. Q2 2024
- New holders
- 4
- 2 more added
- Sold out
- 10
- 0 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ISPC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $152.0K |
| Q1 2026 | 12 | $83.5K |
| Q4 2025 | 11 | $32.9K |
| Q3 2025 | 12 | $443.0K |
| Q2 2025 | 9 | $66.1K |
| Q1 2025 | 8 | $63.7K |
| Q4 2024 | 7 | $94.9K |
| Q3 2024 | 6 | $182.9K |
| Q2 2024 | 13 | $103.1K |
| Q1 2024 | 11 | $69.1K |
| Q4 2023 | 14 | $195.7K |
| Q3 2023 | 13 | $238.5K |
| Q2 2023 | 13 | $596.9K |
| Q1 2023 | 14 | $665.4K |
| Q4 2022 | 13 | $653.0K |
| Q3 2022 | 15 | $781.0K |
| Q2 2022 | 14 | $813.0K |
| Q1 2022 | 13 | $1.98M |
| Q4 2021 | 13 | $9.21M |
| Q3 2021 | 9 | $5.35M |
| Q2 2021 | 7 | $8.10M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding iSpecimen Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 59 | $277 | 0.00% | +16+37.2% | Added |
| Tower Research Capital LLC (TRC) | 1,168 | $5.49K | 0.00% | +1,168 | New |
| UBS Group AG | 1,469 | $6.90K | 0.00% | +1,469 | New |
| BlackRock, Inc. | 2,827 | $13.3K | 0.00% | +2,827 | New |
| FNY Investment Advisers, LLC | 11,500 | $54.0K | 0.03% | +11,500 | New |
| Jane Street Group, LLC | 21,895 | $102.9K | 0.00% | +2,007+10.1% | Added |
| HRT Financial LP | 0 | $0 | 0.00% | −45,935−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −42,087−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −38,498−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −35,987−100.0% | Sold out |
| Grimes & Company, Inc. | 0 | $0 | 0.00% | −30,818−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −25,500−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −14,742−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −13,805−100.0% | Sold out |
| Main Street Financial Solutions, LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Sachetta, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |